KJ Biosciences LLC is a private biotechnology company engaged in developing innovative and enabling technologies and providing novel reagents and services for vaccine and related biomedical research and development.
We aim for original and market-differentiating technologies and products. The company has successfully obtained competitive NIH SBIR grants/contracts for development of novel vaccines including universal influenza vaccine based on the company’s proprietary nanoparticle technologies. The company also develops novel research reagents including specialty antibodies and carrier proteins to serve the biomedical research community.
The company personnel have strong expertise in vaccines, nanoparticle carriers, polysaccharides, and formulation/delivery technologies. Our experience ranges from discovery research, preclinical development, pilot cGMP, IND preparation to IND approval.
We aim for original and market-differentiating technologies and products. The company has successfully obtained competitive NIH SBIR grants/contracts for development of novel vaccines including universal influenza vaccine based on the company’s proprietary nanoparticle technologies. The company also develops novel research reagents including specialty antibodies and carrier proteins to serve the biomedical research community.
The company personnel have strong expertise in vaccines, nanoparticle carriers, polysaccharides, and formulation/delivery technologies. Our experience ranges from discovery research, preclinical development, pilot cGMP, IND preparation to IND approval.
To discover and develop..., there is no expert on unknown™